ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,510Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 1199

$1.35M Total Retail Price of All Prescriptions

Rank: 23 out of 1199

649 Patients Receiving at Least One Drug in Part D
89% Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Virginia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

6% of this provider’s 649 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 649 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Virginia
FUROSEMIDE 975 895 139 1 7
ATORVASTATIN CALCIUM 917 836 138 2 6
SIMVASTATIN 841 749 121 3 2
OMEPRAZOLE 827 713 120 4 5
LEVOTHYROXINE SODIUM 778 702 97 5 4
LISINOPRIL 752 674 115 6 3
HYDROCODONE-ACETAMINOPHEN 688 523 135 S3 7 9
DONEPEZIL HCL 654 654 83 8 30
WARFARIN SODIUM 610 605* 50 9 14
LORAZEPAM 580 544 110 B 10 26
NAMENDA 560 560 64 11 36
METOPROLOL TARTRATE 511 434 80 12 11
POTASSIUM CHLORIDE 497 460 68 13 19
QUETIAPINE FUMARATE 489 435 55 A 14 45
METFORMIN HCL 481 437 73 15 8
AMLODIPINE BESYLATE 396 382 61 16 1
CARVEDILOL 353 335 54 17 22
TRAMADOL HCL 340 304 65 18 18
ZOLPIDEM TARTRATE 323 306 59 19 28
HYDROCHLOROTHIAZIDE 311 272 50 20 10
POLYETHYLENE GLYCOL 3350 291 278 60 21 71
TAMSULOSIN HCL 291 277 41 21 27
TRAZODONE HCL 288 230 40 23 37
CRESTOR 280 275* 49 24 31
CITALOPRAM HBR 279 220 44 25 25
RISPERIDONE 276 212 32 A 26 75
ESCITALOPRAM OXALATE 272 238 52 27 49
ALPRAZOLAM 267 220 46 B 28 21
CLOPIDOGREL 236 196 33 29 20
GABAPENTIN 214 160 38 30 15
KLOR-CON M20 198 175 42 31 48
METOPROLOL SUCCINATE 198 152 30 31 16
LOSARTAN POTASSIUM 189 168 31 33 12
CEFUROXIME 178 159 145 34 139
ALENDRONATE SODIUM 172 172 25 35 43
MONTELUKAST SODIUM 165 98 38 36 42
NAPROXEN 161 121 43 37 113
ATENOLOL 159 154* 23 38 17
DIAZEPAM 159 107 30 B 38 82
FAMOTIDINE* 155 142 25 40 74
ADVAIR DISKUS 148 92 24 41 59
METOLAZONE 145 122 21 42 186
PAROXETINE HCL 142 83 18 43 68
FLUTICASONE PROPIONATE 139 111 25 44 29
ZETIA 137 132* 19 45 65
SERTRALINE HCL 135 130* 26 46 23
ALLOPURINOL 133 128* 24 47 34
GLIPIZIDE 132 117 18 48 50
RANITIDINE HCL 129 111 18 49 41
CYCLOBENZAPRINE HCL 128 104 39 R 50 85
MIRTAZAPINE 124 124 21 51 52
NEXIUM 124 79 26 51 32
NYSTATIN 124 112 49 51 128
CIPROFLOXACIN HCL 115 95 75 54 69
GLIMEPIRIDE 114 109* 14 55 35
PREDNISONE 114 100 38 55 40
AMLODIPINE BESYLATE-BENAZEPRIL 113 100 14 57 77
CLONIDINE HCL 110 105* 22 58 51
DIOVAN 105 100* 13 59 38
LANTUS 104 72 17 60 60
BUSPIRONE HCL 103 64 13 61 109
SPIRIVA 102 76 17 62 63
KLOR-CON M10 98 87 15 63 124
PIOGLITAZONE HCL 96 81 14 R 64 94
CLONAZEPAM 94 57 17 B 65 56
NASONEX 93 65 27 66 211
BETAMETHASONE DIPROPIONATE* 92 77 61 67 360
LEVETIRACETAM 91 64 12 68 83
VESICARE 91 77 14 68 173
MELOXICAM 89 84* 14 70 55
PROMETHAZINE HCL 88 74 55 R 71 104
NIASPAN 87 <11 <11 72 171
DIPHENOXYLATE-ATROPINE 87 82* 44 72 330
AZITHROMYCIN 87 82* 77 72 58
CLOTRIMAZOLE-BETAMETHASONE 86 75 38 75 204
MECLIZINE HCL 85 80* 36 76 119
AGGRENOX 83 83 11 77 157
PANTOPRAZOLE SODIUM 82 69 16 78 24
OLANZAPINE 82 <11 <11 A 78 137
DIGOX 81 69 12 80 101
CEPHALEXIN 80 75* 55 81 99
CELEBREX 79 65 17 82 91
DILTIAZEM 24HR ER 79 66 12 82 105
SPIRONOLACTONE 77 <11 <11 84 61
XARELTO 73 73 12 85 202
DIGOXIN 71 66* 11 86 254
PHENYTOIN SODIUM EXTENDED 71 <11 <11 86 148
SYNTHROID 69 69 14 88 46
KLOR-CON 10 65 60* 12 89 138
TEMAZEPAM 65 54 11 B 89 133
DEXILANT 64 43 11 91 182
JANUVIA 64 <11 <11 91 67
OXYBUTYNIN CHLORIDE ER 64 <11 <11 91 144
NORTRIPTYLINE HCL 62 <11 <11 94 268
VITAMIN D2 62 62 11 94 244
LOPERAMIDE 59 54* 39 96 213
LATANOPROST 59 <11 <11 96 169
ALBUTEROL SULFATE 58 53* 14 98 111
CYMBALTA 57 <11 <11 99 54
PRAVASTATIN SODIUM 57 <11 <11 99 13
TRAVATAN Z 57 <11 <11 99 249
DILTIAZEM HCL 56 <11 <11 102 224
VALSARTAN-HYDROCHLOROTHIAZIDE 56 <11 <11 102 70
AMIODARONE HCL 55 <11 <11 104 174
PRIMIDONE 54 <11 <11 105 266
PROPRANOLOL HCL 54 49* 12 105 140
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 <11 <11 107 33
IBUPROFEN 52 37 11 108 78
BENZTROPINE MESYLATE 52 <11 <11 R 108 158
VOLTAREN 52 <11 <11 108 143
OXYBUTYNIN CHLORIDE 52 <11 <11 108 160
METHOTREXATE 51 <11 <11 112 241
IPRATROPIUM-ALBUTEROL 51 46* 14 112 127
PROAIR HFA 51 40 15 112 44
OXYCODONE-ACETAMINOPHEN 51 46* 16 S2 112 66
FLUOXETINE HCL 51 <11 <11 112 73
LYRICA 50 <11 <11 117 117
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.